NEW YORK, Nov. 26, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning,
Market Source Research released its latest key findings for all current investors, traders, and shareholders of Celldex
Therapeutics, Inc. (NASDAQ:CLDX), InnSuites Hospitality Trust (NYSE:IHT), Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX), EMX Royalty
Corp. (NYSE:EMX), FTE Networks, Inc. (NYSE:FTNW), and Xinyuan Real Estate Co Ltd (NYSE:XIN), including updated fundamental
summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
CLDX DOWNLOAD: http://MarketSourceResearch.com/register/?so=CLDX
IHT DOWNLOAD: http://MarketSourceResearch.com/register/?so=IHT
KERX DOWNLOAD: http://MarketSourceResearch.com/register/?so=KERX
EMX DOWNLOAD: http://MarketSourceResearch.com/register/?so=EMX
FTNW DOWNLOAD: http://MarketSourceResearch.com/register/?so=FTNW
XIN DOWNLOAD: http://MarketSourceResearch.com/register/?so=XIN
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Market Source Research, available for free download at the links above, examine
Celldex Therapeutics, Inc. (NASDAQ:CLDX), InnSuites Hospitality Trust (NYSE:IHT), Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX), EMX
Royalty Corp. (NYSE:EMX), FTE Networks, Inc. (NYSE:FTNW), and Xinyuan Real Estate Co Ltd (NYSE:XIN) on a fundamental level and
outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management
discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's
readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone
summaries and as such, important information may be missing from these samples. Please download the entire research report, free of
charge, to ensure you are reading all relevant material information. All information in this release was accessed November 23rd,
2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
CELLDEX THERAPEUTICS, INC. (CLDX) REPORT OVERVIEW
Celldex Therapeutics' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Celldex Therapeutics reported revenue
of $0.94MM vs $3.92MM (down 76.02%) and analysts estimated basic earnings per share -$0.04 vs -$0.20. For the twelve months ended
December 31st, 2017 vs December 31st, 2016, Celldex Therapeutics reported revenue of $12.74MM vs $6.79MM (up 87.78%) and analysts
estimated basic earnings per share -$0.72 vs -$1.27. Analysts expect earnings to be released on March 6th, 2019. The report will be
for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.17. The estimated EPS
forecast for the next fiscal year is -$0.48 and is expected to report on March 6th, 2019.
To read the full Celldex Therapeutics, Inc. (CLDX) report, download it here: http://MarketSourceResearch.com/register/?so=CLDX
-----------------------------------------
INNSUITES HOSPITALITY TRUST (IHT) REPORT OVERVIEW
InnSuites Hospitality Trust's Recent Financial Performance
For the three months ended July 31st, 2018 vs July 31st, 2017, InnSuites Hospitality Trust reported revenue of
$2.45MM vs $2.11MM (up 15.77%) and analysts estimated basic earnings per share -$0.07 vs $0.96. For the twelve months ended January
31st, 2018 vs January 31st, 2017, InnSuites Hospitality Trust reported revenue of $10.77MM vs $9.20MM (up 17.07%) and analysts
estimated basic earnings per share $0.71 vs -$0.27. Analysts expect earnings to be released on December 21st, 2018. The report will
be for the fiscal period ending October 31st, 2018.
To read the full InnSuites Hospitality Trust (IHT) report, download it here: http://MarketSourceResearch.com/register/?so=IHT
-----------------------------------------
KERYX BIOPHARMACEUTICALS, INC. (KERX) REPORT OVERVIEW
Keryx Biopharmaceuticals' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Keryx Biopharmaceuticals reported
revenue of $28.04MM vs $15.00MM (up 86.96%) and analysts estimated basic earnings per share -$0.14 vs -$0.20. For the twelve months
ended December 31st, 2017 vs December 31st, 2016, Keryx Biopharmaceuticals reported revenue of $60.64MM vs $31.98MM (up 89.60%) and
analysts estimated basic earnings per share -$1.43 vs -$1.52. Analysts expect earnings to be released on February 6th, 2019. The
report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$0.26. The
estimated EPS forecast for the next fiscal year is -$0.14 and is expected to report on February 6th, 2019.
To read the full Keryx Biopharmaceuticals, Inc. (KERX) report, download it here: http://MarketSourceResearch.com/register/?so=KERX
-----------------------------------------
EMX ROYALTY CORP. (EMX) REPORT OVERVIEW
EMX Royalty's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, EMX Royalty reported revenue of $0.43MM
vs $0.80MM (down 46.25%) and basic earnings per share -$0.05 vs -$0.03. For the twelve months ended December 31st, 2017 vs December
31st, 2016, EMX Royalty reported revenue of $2.20MM vs $1.68MM (up 31.06%) and analysts estimated basic earnings per share -$0.07
vs -$0.03. Analysts expect earnings to be released on March 25th, 2019. The report will be for the fiscal period ending December
31st, 2018.
To read the full EMX Royalty Corp. (EMX) report, download it here: http://MarketSourceResearch.com/register/?so=EMX
-----------------------------------------
FTE NETWORKS, INC. (FTNW) REPORT OVERVIEW
FTE Networks' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, FTE Networks reported revenue of
$92.22MM vs $79.08MM (up 16.62%) and analysts estimated basic earnings per share -$1.89 vs $0.47. For the twelve months ended
December 31st, 2017 vs December 31st, 2016, FTE Networks reported revenue of $243.41MM vs $12.27MM (up 1,883.94%) and analysts
estimated basic earnings per share -$4.23 vs -$0.10. Analysts expect earnings to be released on April 16th, 2019. The report will
be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$2.83. The estimated EPS
forecast for the next fiscal year is $1.12 and is expected to report on April 16th, 2019.
To read the full FTE Networks, Inc. (FTNW) report, download it here: http://MarketSourceResearch.com/register/?so=FTNW
-----------------------------------------
XINYUAN REAL ESTATE CO LTD (XIN) REPORT OVERVIEW
Xinyuan Real Estate's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Xinyuan Real Estate reported revenue of
$595.46MM vs $482.37MM (up 23.44%) and analysts estimated basic earnings per share $0.32 vs $0.22 (up 45.45%). For the twelve
months ended December 31st, 2017 vs December 31st, 2016, Xinyuan Real Estate reported revenue of $1,976.91MM vs $1,561.63MM (up
26.59%) and analysts estimated basic earnings per share $0.98 vs $1.10 (down 10.91%). Analysts expect earnings to be released on
February 8th, 2019. The report will be for the fiscal period ending December 31st, 2018.
To read the full Xinyuan Real Estate Co Ltd (XIN) report, download it here: http://MarketSourceResearch.com/register/?so=XIN
-----------------------------------------
ABOUT MARKET SOURCE RESEARCH
Market Source Research delivers the key research reports that helps serious investors, registered brokers,
professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team
is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA®
BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source
Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on
individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well
as granular detail.
REGISTERED MEMBER STATUS
Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes
qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers.
Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside
audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries
regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by
E-mail at compliance@MarketSourceResearch.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source
Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that
result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness
of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated
for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial
advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration.
For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com
© 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network
manager at partnership@MarketSourceResearch.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority,
Inc.